Palomino Laboratories Inc.
Close on Oct 15, 2026
- Market cap
- $305.46M
- P/E (TTM)
- –
- Dividend yield
- –
About Palomino Laboratories
Semiconductors & Related Devices, SIC 3674
Palomino Laboratories Inc. is a pre-revenue technology company developing optical interconnect solutions to transmit data using light instead of conventional copper wiring. The company designs optical transceivers incorporating gallium nitride microLEDs, which can integrate directly onto computer chips or connectors. Its product development focuses on high-speed, low-power optical links for PCIe Gen 6+ and Ethernet backplanes. Palomino targets organizations operating data-intensive environments, including hyperscale data center operators, artificial intelligence and machine learning infrastructure providers, high-performance computing clusters, networking equipment manufacturers, and semiconductor firms implementing chiplet architectures.
Palomino operates under a fabless business model, focusing on device design, packaging, and commercialization rather than internal fabrication. The company conducts research and development activities in collaboration with the University of California, Santa Barbara, utilizing licensed microLED technology. Its principal executive offices are located in Goleta, California.
Summary of the business section of Palomino Laboratories's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Palomino Laboratories Inc.
- Founded
- 2022
- Headquarters
- Goleta, CA
- Address
- 130 Castilian Drive, Suite 102 93117
- Phone
- (917) 200-3734
- Website
- palominolabs.ai
- Employees
- 5, Dec 31, 2025
- Industry
- Semiconductors & Related Devices
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- KNAV CPA LLP, Atlanta, Georgia
Stock & identifiers
- Ticker
- PALX
- Exchange
- OTC
- IPO date
- Apr 14, 2026
- Shares outstanding
- 28M, Aug 4, 2026
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-3.25 reverse, Nov 14, 2025
- SEC CIK
- 1938569
- CUSIP
- 909233108
- ISIN
- US9092331084
- EIN
- 88-1619619
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Richard Ogawa | Secretary, Director | 1,882,500 |
| Jeffrey B. Shealy | President and CEO, Director | 4,666,666 |
| Jason Tu | Chief Accounting Officer | 125,001 |
| Steven Denbaars | Director | 1,762,500 |
Employees
Headcount reported in annual reports
“of December 31, 2025, we had 5 full time employees, no part-time employees, and 13 consultants.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 5, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Oct 6, 2025 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 29, 2025 | Name change | Name changed from Unite Acquisition 3 Corp. to Palomino Laboratories Inc. |